Latest content
-
Read10 Evolved Terms Every Scientist Should Know About Targeted Protein Degradation in 2025
Explore 10 advanced concepts redefining targeted protein degradation in 2025, including AI-guided design, novel degrader modalities, and tissue-specific E3 ligases for scientists working on TPD
-
ReadPushing Boundaries in Biophysics and Biomanufacturing
Marius, a biophysics expert at Johnson & Johnson Innovative Medicine, shares his insights into this rapidly evolving field of biomanufacturing.
-
ReadBinding Affinity Explained - Your guide to understand, evaluate, and purchase the best solution for your lab.
Whether you’re just starting to learn about binding interactions or you want a refresher, this guide provides helpful tips to better understand, evaluate, and eventually purchase the best technology
-
21:30WatchFluorescence-Based Technologies for Binding Affinity Studies: Benefits and Labeling Best Practices
Regardless of fluorescence technology (i.e Spectral Shift, TRIC, or FRET), optimizing your labeling strategy is essential to minimize impact on the functionality and ensure accurate Kd measurements
-
ReadNanoTemper Announces Leadership Evolution: Philipp Baaske Transitions to Executive Chairman
NanoTemper Technologies is entering a new chapter of leadership. After 16 years as Co-CEOs, Philipp Baaske and Stefan Duhr have redefined their roles to better position the company for continued growt
-
ReadNanoTemper Technologies unveils Dianthus uHTS — the fastest biophysical method on the market
NanoTemper Technologies has established an advisory board consisting of five distinguished professionals, each a seasoned expert in their respective fields. This move underscores NanoTemper...
-
ReadNanoTemper Technologies Establishes Advisory Board to Propel Innovation and Growth
NanoTemper Technologies has established an advisory board consisting of five distinguished professionals, each a seasoned expert in their respective fields. This move underscores NanoTemper...
-
ReadNanoTemper brings Spectral Shift technology to the protein production market with Andromeda X, enabling biopharma and CROs
NanoTemper Technologies, well known for creating biophysical tools that accelerate the work of drug discovery researchers, brings their groundbreaking Spectral Shift technology to the protein...
-
0:40WatchWhat are ADCs and how do they work against cancer?
In this short animated video, learn the basics of how antibody-drug conjugates (ADCs) are engineered and why that makes them such powerful tools to target cancers with precision.
- Contact Specialist
-
ReadAttend these targeted protein degradation conferences in 2024 to stay in the know
Attending dedicated targeted protein degradation conferences and tracks is a great way to keep up with this rapidly evolving field. Here are 8 conferences you’ll want to attend in 2024.
-
ReadHow early discovery and development teams use DLS to de-risk downstream biologics development
As a discovery or early development scientist, you’re tasked with identifying the most promising biologics candidates. Your hard work during early development enables straightforward and efficient...
-
Read8 Targeted Protein Degradation conferences in 2023 you won’t want to miss
2023 is expected to be a year of big announcements in the targeted protein degradation (TPD) therapeutics space. With more than 20 degraders in clinical trials, many decisions are coming. The race...
-
ReadGet more information about your protein expression conditions in less time with Andromeda
Get more information about your protein expression conditions in less time with Andromeda
-
ReadFor protein degraders to tackle neurodegenerative diseases, these are the barriers they need to overcome
The total protein degradation modality — locally and specifically targeting the disease-causing proteins and degrading their toxic aggregates — promises to be revolutionary. But the development of...
-
ReadNanoTemper gets Top 100 award as one of Germany’s most innovative SMEs in 2021
NanoTemper has been given this year’s TOP 100 seal, an award that honors innovative German small and medium-sized companies. The TOP 100 innovation competition is organized by compamedia, and...
-
ReadNanoTemper launches Andromeda, helping Biopharma and CROs to increase efficiency of expression screening for membrane proteins
SOUTH SAN FRANCISCO, Calif. June 24, 2021 — NanoTemper Technologies, well-known for creating biophysical tools that tackle challenging characterizations, enters the protein production market with...
-
Read
Fast expression screening that reveals expression levels of properly folded recombinant proteins
-
ReadNanoTemper and SIRION Biotech support Adrian Bleninger’s bid for round-the-world sailing race, the Vendée Globe
NanoTemper Technologies and SIRION Biotech, two of Munich’s rapidly growing biotech companies, are lending their support to Adrian Bleninger, a 30-year-old Bavarian sailor, in his bid to qualify...
-
ReadNanoTemper named one of Germany’s most innovative companies in 2021 by Capital
For the second year in a row, NanoTemper was named one of the most innovative companies in Germany by Capital magazine. A five out of five star distinction placed NanoTemper in the ranking’s top...
-
ReadNanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities
NanoTemper Technologies and PharmAI combine competencies to develop biophysical tools that remove costly and time-consuming guesswork from large datasets.
-
Loading more...
